NEWS

2010-08-23  FDA grants Orphan Drug Status for to-BBB's lead product
2010-06-14  to-BBB receives positive opinion for Orphan Drug Designation
2010-05-31  i-Optics 2nd place in Dutch Innovation top 100
2010-05-20  to-BBB announces pilot study with Janssen Pharmaceutica
2010-04-19  ActoGeniX appoints new Chief Executive Officer
2010-04-08  Biocartis raises EUR 30 million
2010-03-23  Aquapharm appoints new CEO and closes financing round
2010-03-15  Avantium wins Clean Technology Business Award
2010-03-03  to-BBB and GSK to collaborate on brain delivery
2010-02-26  Avantium appoints former Shell CTO to its Supervisory Board
2010-02-10  Biocartis acquires Philips-platform
2010-01-06  f-star raises EUR 8m in extended Series A Financing
2009-12-22  to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases
2009-12-16  Avantium appoints Gunnar Staaf as CEO Pharma
2009-12-02  Rainer Christine joins Aescap Venture as Partner
2009-11-06  Avantium and AMS start collaboration on Crystal Structure Prediction
2009-11-03  to-BBB signs collaboration with Genzyme
2009-10-15  Aescap leads financing of Biocartis
2009-10-09  ActoGeniX completes Phase 2A clinical trial of AG011
2009-09-17  to-BBB technology will be used by MedImmune to evaluate brain drug delivery mechanism
2009-09-11  ProtAffin AG granted patent in USA for lead anti-inflammatory product PA401
2009-08-20  ActoGeniX starts clinical trial in oral mucositis
2009-07-30  Aescap Venture invests in EOS
2009-07-09  NatureWorks and Avantium to Collaborate on a New Generation of Biobased Polymers
2009-05-14  ActoGeniX obtains IND approval
2009-05-01  f-star hires Kevin FitzGerald as new CEO
2009-04-27  ProtAffin completes EUR 14 million Financing Round
2009-04-02  Affectis and Mitsubishi Tanabe Pharma enter drug discovery collaboration
2009-02-11  Actogenix completes equity financing round of 13.5 million euro
2009-02-03  Blood-brain barrier company to-BBB moves into commercialization mode with new CEO Willem van Weperen
2009-01-29  Actogenix, levende pil tegen darmziekte
2009-01-23  ProtAffin AG granted patent in EU for lead anti-inflammatory product PA401
2009-01-22  Avantium launches the Crystalline, a new parallel system for crystallization research.
2009-01-21  Cosun and Avantium announce collaboration
2008-11-08  Dutch biotech company to-BBB and Taiwanese ITRI sign exclusive license agreement
2008-10-29  Avantium completes EUR 18 million financing
2008-09-22  Vivendy Announces Management and Board Changes
2008-09-17  Vivendy’s Treatment for Morbus Morquio (MPS IVA) Granted Orphan Drug Designation by FDA
2008-09-11  Actogenix announces start of phase 2a clinical trial
2008-09-05  ProtAffin AG granted Orphan Drug Designation in the US for lead anti-inflammatory product
2008-08-04  Aquapharm signes license deal with Croda
2008-07-18  ProtAffin AG receives Orphan Medicinal Product Designation from EMEA for PA401
2008-07-09  Aquapharm and Dr. Reddy’s Sign Commercial License Agreements
2008-07-08  Aquapharm and Dr. Reddy\'s Sign License Agreement
2008-06-23  Aescap Venture invests in Vivendy Therapeutics Ltd.
2008-06-16  Aquapharm CEO wins Ernst & Young Scotland entrepreneur of the year award 2008
2008-05-28  to-BBB invited to pitch at BioEquity Europe
2008-05-14  Actogenix completes manufacturing of clinical product
2008-05-14  ActoGeniX completes manufacturing of its clinical product AG011 and prepares for phase 2 clinical trial
2008-04-02  ProtAffin AG announces R&D collaboration with Intercell AG
2008-03-28  F-Star Buys Back Royalty Obligations. TVM Capital Joins Investor Syndicate
2008-03-13  f-star opens research site in Cambridge, UK
2008-02-04  Anders Waas appointed as VP business development Actogenix
2008-01-28  Appointment Supervisory Board
2007-12-19  3 antibody pioneers join f-star scientific advisory board
2007-11-29  F-Star raises EUR 3.0 M in a Second Closing
2007-11-16  Aescap Venture takes 25% stake in i-Optics
2007-10-15  Affectis starts phase II clinical trial
2007-09-12  Aescap leads investment in f-Star
2007-07-31  Aescap invests in new antibiotics
2007-07-07  Vivendy Therapeutics Ltd. signs exclusive Patent Licensing Agreement for the development of an Enzyme Replacement Therapy for Morbus Morquio
2007-07-04  Aescap invests EUR 4 M in TO-BBB
2007-05-07  Aescap leads investment in ProtAffin AG
2007-01-31  Aescap invests in Actogenix NV
2007-01-08  Starters in biotech populair bij investeerders
2007-01-08  Aescap ventures exeeds 100M level
2006-10-24  Venture leads 12 million euro financing in Affectis Pharmaceuticals AG